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1 Introduction 
Aquaporin (AQP) water channels are small hydrophobic integral membrane proteins which 
enable the passive rapid movement of water across the cell membrane. (Denker et al., 1988) 
There are three subfamilies of this water channel, according to their permeability. Classical 
AQPs are AQP0, 1, 2, 4, 5, 6, and 8, which selectively permeable to water. (Ishibashi et al., 
2011) While aquaglyceroporins allow not only the transport of water but also non-polar 
solutes, such as glycerol, urea and gases, like carbon dioxide and ammonia. This subfamily 
contains AQP3, 7, 9, and 10. (Hara-Chikuma and Verkman, 2006; Madeira et al., 2015) 
Unorthodox AQPs include AQP11 and 12; the function of them is under investigation. (Itoh 
et al., 2005; Yakata et al., 2007) 
Structural studies revealed that the monomer units of this water channel consist of six 
transmembrane α-helices and five connecting loops. (Eriksson et al., 2013) Loops B and E 
contain the conserved Asn-Pro-Ala (NPA) motifs, which fold as seventh pseudo 
transmembrane helix insert from the opposite sides of the membrane. These motifs located 
near the center of the water pore and part of the hydrophilic surface of natural dipole pore. 
The selectivity of these channels for water is due to the backbone α-carbonyl groups and the 
NPA motifs containing aromatic and arginine residues (Fig. 1). They act as hydrogen-bond 
donors and acceptors that responsible for the coordination of water transport through the 
channel. (Törnroth-Horsefield et al., 2010) 
AQPs are widely expressed in living organisms and their proper function is elemental for 
different physiological processes. In the human body AQP1 is expressed in the central 
nervous system, corneal endothelium, erythrocytes, kidney and in all vascular endothelial 
cells. AQP2 can be found in the kidney, in the luminal side of collecting duct principal cells. 
AQP3 is located in the eyes, lung, kidney, macrophages, T cells, erythrocytes, epidermal cells 
and in the epithelial cells of the intestine. AQP4 is expressed in the astrocytes end-feet, 
lacrimal gland, inner ear, olfactory epithelial cells, stomach, airway cells and in the kidney. 
AQP5 is located in the salivary glands, lacrimal gland, alveolar type I cells and in the uterus. 
AQP7 is expressed in the S3 segment of the proximal tubule and in the adipocytes. AQP8 is 
found in the epithelial cells of the intestine. AQP9 is expressed in the erythrocytes and AQP0 
is expressed in the lens. (Verkman et al., 2014) 
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Figure 1. The structure of AQP water channels. (A) The topologic map of the elemental constructive fold of 
AQP highlighting the unusually long regions.(B) Comprehensive structure of AQPs showing the six trans-
membrane helices (blue) and the two half-helices (yellow) which constitute the pseudo seventh transmembrane 
helix. (C) The conformation of the NPA and ar/R motifs in the AQP channel with the red water molecules. (B) 
and (C) were obtained from the X-ray structure of human AQP5. (Törnroth-Horsefield et al., 2010) 
1.1 The role of the AQP water channels in the female reproductive system 
AQPs can be found in the female reproductive system: in the vagina, cervix, uterus, oviduct, 
ovary, oocyte, and also in the placenta, fetal membrane and in the embryo. (Zhang et al., 
2012) Their importance during the gestation is unquestionable (Table 1). 
AQP1 is primarily expressed in the capillaries and venules of the human vagina and AQP2 in 
the cytoplasm of the vaginal epithelium. AQP3 can be found mainly in the plasma membrane 
of vaginal epithelium. In the cytoplasm of the vaginal epithelium AQP5 and AQP6 are 
located. The location of AQP1, 2, and 3 are very similar in rats to humans. (Park et al., 2008) 
They are responsible for sexual arousal like genital swelling and increased vaginal lubrication. 
(Berman et al., 2000) 
In the human ovary, AQP1 can be found in ovarian microvascular and small vessel epithelial 
cells. (Yang et al., 2005) AQP1, 2, 3, and 4 can be found in both theca and granulose cells of 
human follicles and they show different expression patterns during various stages of 
ovulation. (Thoroddsen et al., 2011) In the oviduct they enable gamete transport and embryo 
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development in the early stage. (Leese et al., 2001) During ovarian folliculogenesis, the 
transcellular water transport is mediated by AQP7, 8, and 9. (McConnell et al., 2002) AQP1, 
3, 8, and 9 are expressed in mouse oocytes and they may affect the oocyte maturation. 
(Edashige et al., 2000) 
In the human uterus and cervix, AQP1 is expressed in the endothelium of small blood vessels. 
AQP2 is predominantly present in luminal and glandular epithelial cells of the endometrium. 
(Feng et al., 2008) AQP3 is localized in basolateral membranes of human uterine 
endometrium, and AQP9 is present in the cytoplasm of epithelial cells of the human oviduct. 
(Ji et al., 2013; Mobasheri et al., 2005) AQP1, 3, and 8 are constitutively expressed in non-
pregnant mice. (Jablonski et al., 2003)  
Richard et al. studied the expression of AQP0 to 9 in mice uterus on days 1 to 8 of gestation. 
They found that, the expression of AQP5 and 9 increased in the glandular epithelium of the 
uterus at the time of implantation. (Richard et al., 2003) Overall, AQP1, 2, 3, 4, 5, 7, 8, and 9 
have been detected in the rat uterus. They take part in endometrial development, cell 
migration, embryo implantation and maybe in myometrial contractions. AQP5 is mainly 
involved in embryo implantation and it is a major regulator during pregnancy. (Ducza et al., 
2014; Lindsay and Murphy, 2007; Zou et al., 2011) The cervix undergoes significant changes 
through pregnancy and labor. Anderson et al. revealed that AQP3, 5 and 8 may responsible 
for the complicated regulations of this tissue. (Anderson et al., 2006) 
The amniotic fluid regulation occurs through the placenta and the fetal membrane; the normal 
volume of amniotic fluid is crucial for maintaining the fetal development. AQP3, 4, 8, and 9 
are located in human syncytiotrophoblasts and AQP1 can be found in placental vessels. 
AQP1, 3, 8, and 9 are located in the human amnion and chorion. (Zhang et al., 2012)
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 AQP1 AQP2 AQP3 AQP4 AQP5 AQP6 AQP7 AQP8 AQP9 AQP10 AQP11 AQP12 
Blastocyts 
(implantation) 
h-R 
 
h-R 
 
h-R 
 
h-R 
 
h-R 
 
h-R 
 
h-R 
 
m-P 
 
h-R 
m-P 
 h-R 
 
h-R 
 
Uterus 
(implantation) 
r-mm-P 
m-mm-P+R 
p-P 
h-em-
P+R 
 
h-em-R 
 
m-mm-P+R 
c-em-R 
m-mm-P+R 
r-mm-P 
p-P 
  m-mm-P r-P+R 
p-P 
   
Amnionic 
membrane 
h-P+R 
o-P+R 
m-fc-P 
 h- P+R 
o-P+R 
m-ec,fc-P 
    h-P+R 
o-P+R 
m-ec-P 
h-P+R 
o-P+R 
m-aec-P 
 h-P+R 
o-P+R 
 
 
Placenta h-pv-R 
r-bz,lz-P 
m-vec-P+R 
o-vec-P+R 
 h-pv-R 
r-R 
m-tec-P+R 
o-tec-P+R 
h-pv-R 
h-st,ec-P 
 
h-pv-R 
 
  h-pv-R 
r-bz, lz-P 
m-P+R 
o-tec-R 
h-pv-R 
r-cp, bz, lz-
P 
m-R 
 
 h-pv-R 
 
 
Uterus  
(late pregnant) 
r-P+R r-P+R r-P+R  r-P+R   r-P+R r-P+R    
Cervix 
(late pregnant) 
  m-bcl-P+R m-acl 
P+R 
m-acl 
P+R 
  m-acl P+R     
 
Table 1. The expression of AQP isotypes in different species during gestation. 
species: h: human; r: rat; m: mouse; c: cattle; o: ovine; p: pig; P: protein, R: mRNA, fc: fibroblast cells; ec. epithelial cells; aec: apoptotic epithelial cells; vec: vascular 
epithelial cells; tec: trophoblast epithelial cells; st: syncytiotrophoblast cells; pv: placenta villi; cp: complete placenta; mm: myometrium; em: endometrium, bcl: basal cell 
layers of cervical epithelium, acl: apical cell layers of cervical epithelium, bz: bazal zone, lz: labyrinth zone (Ducza et al., 2017) 
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1.2 AQP5 in the pregnant rat uterus 
According to the studies of Lindsay et al. it is clear that some AQP isoforms are expressed in 
rat and mouse uterus and the distribution and expression of these channels are regulated 
during the peri-implantation period. (Lindsay and Murphy, 2007, 2006, 2004) There was a 
redistribution of AQP5 from the cytoplasm to the apical plasma membrane at the time of the 
blastocyst implantation. It suggests that AQP5 may allow locating the blastocyst and has a 
crucial role in the reduction of uterine luminal fluid during the implantation. (Lindsay and 
Murphy, 2004) They found elevated AQP5 protein expression in the apical plasma membrane 
of uterine epithelial cells in the same conditions as implantation. (Lindsay and Murphy, 2006) 
In our earlier study we investigated the expression of AQP isoforms in the pregnant rat uterus. 
The mRNAs of AQP1, 2, 3, 5, 8, and 9 isoforms were detectable in the myometrium of non-
pregnant and late pregnant (day 18, 20, 21, 22) rats. Among the six water channel subtypes, 
AQP5 mRNA and protein levels showed the most remarkable changes during pregnancy. 
AQP5 mRNA was the highest on days 18-21 of gestation and dramatically dropped on the last 
day (day 22) of pregnancy. The amount of AQP5 mRNA peaked on day 18, while the AQP5 
protein level was the highest on day 20 of gestation, but also decreased on the last day 
(Fig. 2). In an in vitro study we examined the effect of oxytocin on the expression of AQP5 
on day 18 of pregnancy, when the mRNA level is the highest. We found that AQP5 mRNA 
level significantly decreased within 5 minutes after oxytocin administration. This effect 
occurred via the oxytocin receptor, because the oxytocin receptor antagonist atosiban 
inhibited the effects of oxytocin on the expression of AQP5 mRNA. According these results, 
we suppose that AQP5 is regulated by oxytocin at the end of gestation and may play 
important role in the initiation of delivery. (Ducza et al., 2014) 
There is another study which also revealed that AQP5 was dramatically down regulated 
during parturition. They used microarray analysis to detect the changes of different gene 
expressions in the rat myometrium during late pregnancy and during labor. Helguera et al. 
reported that both AQP5 and AQP8 are upregulated until the first 20 days of gestation. On the 
other hand the protein expression of both water channels showed significant decrease from the 
day 20 to the last day of gestation. (Helguera et al., 2009) 
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Figure 2. Changes in mRNA (A) and protein (B) expression of AQP5 on different days of pregnancy in rat 
uterus and in non-pregnant rat uterus (NP). Amount of AQP5 mRNA (A) and protein (B) were significantly 
reduced on the last day of gestation. ns > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001 compared to the previous 
day. Each bar denotes the mean ± S. D. (Ducza et al., 2014) 
1.3 The effects of sexual hormones on the AQP5 expression 
There are evidences that the expression of water channels is influenced by sexual hormones. 
This is supported by the fact that the expression of AQPs changes according to the menstrual 
cycle. Aralla et al. investigated the water channel regulation in the uterus of cycling bitches, 
and they found that AQP5 was particularly expressed in response to high levels of 
progesterone. (Aralla et al., 2009) Another study revealed that AQP2 expression correlates 
with serum 17β-estradiol and progesterone levels in human endometrium. (He et al., 2006) 
The explanation of these phenomena is that there is an estrogen response element in the 
promoter region of the AQP5 and 2 genes, which provides the immediate regulation of these 
water channels by estrogen. (Kobayashi et al., 2006; Zou et al., 2011) An in vitro study 
investigated the effects of progesterone and estradiol treatments on the AQP5 expression in 
the porcine uterus. They observed the down-regulation of AQP5 gene expression after the 
progesterone and estrogen treatments during the mid-luteal phase, while in the time of 
luteolysis, it was increased by estrogen. (Skowronska et al., 2015) Ovariectomized rats were 
treated with testosterone, estrogen, or combination of them. It was determined that 
testosterone enhanced the expression of AQP5 in the uterus and this effect was abated by a 
consecutive estrogen treatment. (Salleh et al., 2015) It was also observed that AQP5 protein 
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expression increased due to progesterone treatment alone or in combination with estrogen in 
ovariectomized rat uterus. (Lindsay and Murphy, 2006) 
Richard et al. confirmed that AQP1, 4, and 5 are extremely expressed in the peri-implantation 
period in mouse uterus, and AQP5 expression depends on the estrogen stimulation of the 
progesterone-primed uterus. (Richard et al., 2003) According to a study, the location of the 
AQP5 channel changed from the cytoplasm to the apical plasma membrane at the time of 
implantation in the rat uterus and it may enable the proper positioning of the blastocyst. 
(Lindsay and Murphy, 2004) 
1.4 Preterm birth, antibiotic treatment and AQP 
Preterm labor has multiple pathophysiogical background, like infection, allergic phenomena, 
abnormal allograft reaction, ischemia, cervical disease, endocrine disorder or uterine over-
distension. (Romero et al., 2006) It is well known that preterm birth increases prenatal 
morbidity and mortality, which often leads to long-term neurological impairments 
gastrointestinal and respiratory complications in children. (Owen et al., 1993) Genital tract 
infection is a common factor which raises the frequency of preterm delivery. (Joergensen et 
al., 2014) Antibiotics are widely used to diminish the hazard of infection caused preterm 
labor, principally in case of the premature rupture of the membranes (PROM). (Kenyon et al., 
2013) There is a meta-analysis about the effect of prophylactic antibiotic treatment after 
PROM which indicates that, for example amoxicillin could alleviate the prevalence of sepsis 
and intraventricular hemorrhage among newborns. (Egarter et al., 1996) Another meta-
analysis described the importance of antibiotics for asymptomatic bacteriuria in gestation, 
which has been associated with low birth weight and preterm delivery. Antibiotic treatment 
was effective in decreasing the frequency of acute pyelonephritis in the mother. Beside this it 
reduced the incidence of low birth weight babies and preterm birth. It means that these 
children more likely avoid the neonatal complications. (Smaill and Vazquez, 2015) As a study 
revealed, urinary tract infection is successfully treated with a single-dose fosfomycin during 
pregnancy and it was well tolerated. (Krcmery et al., 2001) Beside fosfomycin, amoxicillin is 
also frequently used antibiotic drug for treating bacteriuria and bacterial vaginosis through 
pregnancy. (Duff et al., 1991; Estebanez et al., 2009) These two antibiotics are generally used 
in the treatment of pregnant women but doxycycline is contraindicated. (Bookstaver et al., 
2015) However, it was proven that doxycycline induces AQP5 expression in the lungs of 
transgenic mice; therefore it is the only one known AQP5-influencing antibiotic. (Tichelaar, 
2000) 
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1.5 Transient receptor potential vanilloid 4 and AQP5 channel 
Up to the present day, six subfamilies of transient receptor potential (TRP) channels have 
been identified in mammals. (Rosasco and Gordon, 2017) These six subfamilies are TRPV 
(vanilloid), TRPC (canonical), TRPM (melastatin), TRPA (ankyrin), TRPML (mucolipin), 
and TRPP (polycystin). The seventh subfamily of TRP channels is TRPN (Drosophila 
NOMPC), which only found in invertebrates and fish. (Björkgren and Lishko, 2017) They can 
be activated by diverse stimuli that include voltage; heat; mechanical force; for example 
osmotic differences, pressure, shear stress and chemicals; such as capsaicin, menthol, Ca2+, 
calmodulin, pH. (Zheng, 2013) 
TRPV4 is activated by different physical (heat, cell swelling, mechanical stimuli) and 
chemical (endocannabinoids, arachidonic acid) impacts. (Vennekens et al., 2008) These 
channels are members of the voltage-gated superfamily of ion channels within this they 
belong to voltage gated K+, Na+, and Ca2+ channels. The TRP channels have tetramer form 
and they can appear as homo and also as heterotetramers. All of the subunits contain six 
membrane-spanning helices with a reentrant pore loop, which is located between the fifth and 
sixth transmembrane helices. We can found also an intracellular amino- and carboxy-terminal. 
Four transmembrane portions (Fig. 3) construct the voltage-sensing or voltage-sensing-like 
region. The other two transmembrane part of the channel build up the ion-conducting pore. 
(Rosasco and Gordon, 2017) 
 
Figure 3. The structure of the TRP channels. The upper line shows the structures of the TRP channels. 
Different colors indicate the building subunits. On the bottom of the picture we can see the enlarged subunit of 
TRPV1. Parts of this unit are the voltage sensor-like domain (blue), pore domain (yellow), the pre-S1 domain 
(pink), and the ankyrin repeat domain (green). (Rosasco and Gordon, 2017) 
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The distribution in the tissues and the function of TRP channels are very diverse (Fig. 4). In 
the human body they play role in the brain and nervous system, the following channels 
expressed here: TRPC1; TRPV2, -4, -5, -6; TRPM2, -4, -5, -6, -7; TRPP1, -2, -3; TRPML1, -
2 and TRPA1. Some of the TRP channels can be found in the pulmonary, cardiovascular, 
renal, digestive, integumentary system and in the liver. These channels take place also in the 
reproductive system, TRPC1, -3, -6; TRPV2, -4, -5, -6; TRPM2, -4, -5, -6, -7; TRPP1, -2, -3; 
TRPML1, -2; TRPA1. (Rosasco and Gordon, 2017) 
 
 
 
Figure 4. The distribution of TRP channels in the human body. Different TRP channels are listed on the 
right side of the picture. The colored squares mean where these channels can be found. Square with a white 
border indicate the presence of RNA expression, and the square with a black border demonstrate the existence of 
protein expression of the mentioned TRP channel. The meaning of the colors: orange: brain/nervous system; 
yellow: pulmonary system; red: cardiovascular system; purple: renal system; dark blue: liver; light blue: 
digestive system; pink: integumentary system; and green: reproductive system. (Rosasco and Gordon, 2017) 
 
As seen on the figure, TRPV channels are expressed in the male and female reproductive 
tissues and play crucial regulatory task in various physiological actions. They are responsible 
for oocyte maturation and activation and for the fertilization. (Björkgren and Lishko, 2017) 
Expression of TRPV4 mRNA was observed in rat prostatic tissue. (Guibert et al., 2011) 
TRPV1 is present in human placenta and the deregulation in TRPV1 expression was found in 
preeclampsia. (Martínez et al., 2016)  
It is supported by numerous evidences that AQP5 water channel is an interacting partner of 
TRPV4 channel. A study indicates that hypotonic reduction of AQP5 expression requires 
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TRPV4. (Liu et al., 2006) Based on this article, the cooperation of TRPV4 and AQP5 is 
essential for the mechanism of regulatory volume decrease (RVD) in salivary gland cells. It is 
proved that AQP5 necessary for salivary fluid secretion and this channel regulates the volume 
of acinar cells. So the functional connection was recognized between AQP5 and TRPV4 in 
these cells. (Aure et al., 2010) 
TRPV4 is the osmosensor by hypotonicity-activated Ca2+ entry pathway. In this process 
AQP5 regulates the water permeability and the cell volume. 
A study revealed the decreased expression of AQP5 depends on the TRPV4 channel in hypo-
osmotic conditions. Plenty of AQP5 is coordinated by extracellular osmolalities and it can be 
regulated in hypotonic circumstances by TRPV4 activation. (Sidhaye et al., 2006) 
The activation of TRPV4 channel causes nitric oxide and endothelium-derived 
hyperpolarizing factor (EDHF)-mediated endothelium-dependent relaxation in the rat 
pulmonary artery. (Sukumaran et al., 2013) TRPV4 channel mediated EDHF-type activation 
implicates the gestation-induced remodeling and vasodilatation in uterine radial artery of 
pregnant rats. (Senadheera et al., 2013) In the myometrial smooth muscle cells, the external 
Ca2+ entry is essential for the uterine contraction. Among other voltage-gated calcium 
channels, the TRPV4 channel is a potential candidate concerned in Ca2+ entry generating 
myometrial contractions. (Matthew et al., 2004; Ying et al., 2015) 
Ying et al. found that TRPV4 gene and protein expression elevated during pregnancy in 
murine model. The TRPV4-mediated Ca2+ entry and contractility were raised in myometrial 
smooth muscle cells of pregnant mice compared to the non-pregnant. They proved also the 
direct pharmacological stimulation of TRPV4 escalate uterine contraction. (Ying et al., 2015) 
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2 Aims 
 
The dynamic change of AQP5 expression was proved during pregnancy so we investigated 
the hormonally effects on the AQP5 expression. The first aim of our study was (1) to identify 
the effects of estrogen and progesterone receptor agonists pretreatment on the mRNA and 
protein expressions of AQP5 in the rat uterus during the terminal phase of gestation. To attain 
this goal we have (2) determined the changes of AQP5 expression in the hormonally-induced 
preterm birth model also.  
 
The usage of some antibiotics is allowed during pregnancy but limited information is 
available about their effect on AQP5 expression and thereby on uterine contraction. Therefore 
our next aim was to (3) investigate the changes of the AQP5 expression and uterine 
contraction after antibiotic (amoxicillin, fosfomycin, doxycycline) pretreatment to determine 
the effect of these prophylactic antibiotics on preterm birth. 
 
We hypothesized an osmotic pathway - through AQP5 - might have influence on the changes 
of TRPV4 function and uterus contraction. To prove this, we (4) investigated the co-
expression and cooperation of AQP5 and TRPV4 in the pregnant uterus and (5) their mutual 
regulatory effect on myometrial contraction.  
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3 Materials and methods 
3.1 Housing and handling of the animals  
The animals were treated in accordance with the European Communities Council Directives 
(2010/63/EU) and the Hungarian Act for the Protection of Animals in Research (Article 32 of 
Act XXVIII). Experiments involving animal subjects were carried out with the approval of 
the Hungarian Ethical Committee for Animal Research (permission numbers: IV/198/2013 
and IV/3796/2015.)  
The experimental animals were purchased from INNOVO Ltd. (Gödöllő, Hungary) and were 
kept at a controlled temperature (20-23 °C), in relative humidity of 40-60% and under a 12 h 
light/dark cycle. The experimental animals were fed a standard rodent pellet diet (INNOVO 
Ltd., Gödöllő, Hungary) and tap water was available ad libitum. 
3.2 Mating of the animals 
The mature Sprague-Dawley rats (females 180-200g and males 240-260g) were mated in a 
special mating cage, which has a time-controlled mobile metal door. The male and female 
animals are separated until the gate opened in the early morning hours, because rats are active 
nocturnally. Four or five hours after the possible sexual intercourse, swabs were taken from 
the vagina of the female rats. In case of the existence of sperms in the native vaginal smear or 
the presence of copulation plug the female animals were regarded and separated as first-day 
pregnant rats. 
3.3 Treatments of the rats 
3.3.1 In vivo female sexual hormone treatments of the rats 
The pretreatment of pregnant animals with 17β-estradiol valerate, tamoxifen citrate, and 
clomiphene citrate (Sigma-Aldrich, Budapest, Hungary) was started on day 14 and day 18 of 
gestation. The active agents were suspended in olive oil and injected subcutaneously in a dose 
of 1 µg/0.1 ml of 17β-estradiol (Bóta et al., 2015; Hódi et al., 2014); 5 mg/0.1 ml of 
tamoxifen citrate (Cyr, 2000); and 1 mg/0.1 ml of clomiphene citrate (Bharti et al., 2013; 
Nutu et al., 2010) once a day for four days. On day 18 and the last day of pregnancy, day 22, 
the uterine samples were collected and molecular studies were carried out. 
The pregnant rats were treated with progesterone, levonorgestrel, and medroxyprogesterone 
acetate (Sigma-Aldrich, Budapest, Hungary) from day 11 and 15 of gestation. The compounds 
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were suspended in olive oil. The animals were injected subcutaneously every day with 
0.5 mg/0.1 ml of progesterone and levonorgestrel, and 5 mg/0.1ml of medroxyprogesterone 
acetate for seven days.(Bóta et al., 2015; Brandon and Raval, 1979; Graham and Milad, 2013; 
Hódi et al., 2014) On day 18 and 22, the uterine samples were collected and molecular studies 
were carried out. We chose these durations for the hormonal treatments according to our 
earlier investigations. 
We treated the preterm birth group as reported by Elovitz et al..(Elovitz and Mrinalini, 2004) 
The pregnant rats received mifepristone (Sigma-Aldrich, Budapest, Hungary), dissolved in 
olive oil. It was injected subcutaneously in a dosage of 3 mg/0.1 ml on day 19 of pregnancy at 
9 A.M.. The intravaginal prostaglandin E2 was given at a dose of 0.5 mg/ml on the same day 
at 4 P.M.. Next day appear preterm delivery on day 20 of gestation. After the beginning of the 
preterm birth, uterine samples were collected and molecular studies were carried out. 
3.3.2 In vivo antibiotic treatments of the rats 
The pregnant animals received amoxicillin from the day 16 of gestation. The Ospamox 
granulates for suspension (Sandoz Ltd. Kundl, Austria) was given orally in a dose of 
40 mg/kg of body weight by oral gavage once a day for seven days. (Berney and Francioli, 
1990; Moreillon et al., 1986) We prepared the suspension with purified water. On the last day 
of pregnancy (day 22) uterine samples were collected and molecular studies were carried out.  
The fosfomycin treatment of the pregnant rats was started on day 21 of gestation. The solution 
was prepared with purified water. The animals were treated orally by oral gavage with 
Monural granulates (Zambon Ltd. Bresso, Italy) in a dose of 40 mg/kg of body weight once. 
(Lingscheid et al., 2015; Ozok et al., 2012) On the last day of pregnancy (day 22) uterine 
samples were collected and molecular studies were carried out.  
The pregnant rats got the doxycycline treatment from the day 16 of gestation. They received 
Doxycylin AL (AliudPharma Ltd. Laichingen, Germany) (100 mg hard capsule) in a dose of 
30 mg/kg of body weight once a day for seven days, orally by oral gavage. (Mata et al., 2015; 
Wang et al., 2014) The suspension was prepared by opening the capsules and grinding the 
powder with methyl cellulose. On the last day of pregnancy (day 22) uterine samples were 
collected and molecular studies were carried out.  
The durations of the therapies were determined based on human therapeutic protocols. (Bader 
et al., 2017; Coker and Dierfeldt, 2016; Dijkmans et al., 2017) 
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3.4 RT-PCR Studies 
3.4.1 Tissue Isolation 
The experimental animals (250-300 g) were sacrificed by CO2 inhalation and newborn rats 
were sacrificed by immediate cervical dislocation. Uterine tissues, tissue between two 
implantation sites, from pregnant animals (n=6 in each experiment) were rapidly removed and 
placed into RNAlater Solution (Sigma-Aldrich, Budapest, Hungary). The tissues were frozen 
in liquid nitrogen and stored at -75°C until the extraction of total RNA. 
3.4.2 Total RNA Preparation 
Total cellular RNA was isolated by extraction with guanidinium thiocyanate-acid-phenol-
chloroform according to the procedure of Chomzynski and Sacchi (Chomzynski, 1987). After 
precipitation with isopropanol, the RNA was washed with 75% ethanol and then resuspended 
in diethyl pyrocarbonate-treated water. RNA purity was controlled at an optical density of 
260/280 nm with BioSpec-nano (Shimadzu, Kyoto, Japan); all samples exhibited an 
absorbance ratio in the range of 1.6-2.0. RNA quality and integrity were assessed by agarose 
gel electrophoresis. 
3.4.3 Real-Time Quantitative Reverse-Transcriptase PCR 
Reverse transcription and amplification of the PCR products were performed by using the 
TaqMan RNA-to-CT-Step One Kit (Thermo Fisher Scientific, Budapest, Hungary) and an 
ABI StepOne Real-Time cycler. Reverse-transcriptase PCR amplifications were performed as 
follows: 48°C for 15 min and 95°C for 10 min, followed by 40 cycles at 95°C for 15 sec and 
60°C for 1 min. The generation of specific PCR products was confirmed by melting curve 
analysis. Table 2 contains the assay IDs for the primers used and the reaction parameters. All 
samples were run in triplicate. The fluorescence intensities of the probes were plotted against 
PCR cycle number. The amplification cycle displaying the first significant increase of the 
fluorescence signal was defined as the threshold cycle (CT). 
 
TaqMan 
Assays 
Assay ID 
(ThermoFisher 
Scientific) 
Accession 
Number 
Assay 
Location 
Amplicon 
Length 
Annealing 
Temp. (C°) 
Reaction 
Volume 
(µl) 
AQP5 Rn00562837_m1 NM_012779.1 473 69 60 20 
TRPV4 Rn00576745_m1 NM_023970.1 950 59 60 20 
β-actin Rn00667869_m1 NM_031144.3 881 91 60 20 
 
Table 2. Parameters of the applied primers and PCR reactions. In our studies the parameters of inventoried 
TaqMan assays were defined by Life Technologies (Thermo Fisher Scientific, Budapest, Hungary). 
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3.5 Western Blot Analysis 
The uterine tissues from pregnant rats (tissue between two implantation sites) were 
homogenized using a Micro-Dismembrator (Sartorius AG, Goettingen, Germany) and 
centrifuged at 5,000×g for 15 min at 4°C in RIPA Lysis Buffer System (Santa Cruz 
Biotechnology, Inc., Dallas, TX, USA), which contains phenylmethylsulfonyl fluoride 
(PMSF), sodium orthovanadate and protease inhibitor cocktail. Total protein amounts from 
supernatant were determined by spectrophotometer (BioSpec-nano, Shimadzu, Japan). 
Twenty-five micrograms of sample protein per well was subjected to electrophoresis on 4%-
12% NuPAGE Bis-Tris Gel in XCell SureLock Mini-Cell Units (Thermo Fisher Scientific, 
Budapest, Hungary). Proteins were transferred from gels to nitrocellulose membranes using 
the iBlot Gel Transfer System (Thermo Fisher Scientific, Budapest, Hungary). Ponceau S 
(Sigma-Aldrich, Budapest, Hungary) was used to check the standard running and transfer 
conditions. The blots were incubated overnight on a shaker with AQP5 (35 kDa), TRPV4 
(98 kDa) and β-actin (43 kDa) polyclonal antibodies (Santa Cruz Biotechnology, Inc., Dallas, 
TX, USA, diluted 1:200, host: rabbit, specificity: mouse, rat and human) in blocking buffer. 
Antibody binding was detected with the Western Breeze® Chromogenic immunodetection kit 
(Thermo Fisher Scientific, Budapest, Hungary).  
Images were captured with the EDAS290 imaging system (Csertex Ltd., Budapest, Hungary), 
and the optical density of each immunoreactive band was determined with Kodak 1D Images 
analysis software. The β-actin was used for protein normalization for this semi-quantitative 
method. Optical densities were calculated as arbitrary units after local area background 
subtraction. 
3.6 Immunohistochemistry 
The localization of TRPV4 and AQP5 in the uterus was examined by immunohistochemistry. 
Late pregnant (pregnancy days 18 and 22) uteri were fixed in paraformaldehyde and then 
embedded in paraffin, sectioned (5-μm-thick tissue sections) deparaffinized, rehydrated and 
incubated in acidic citrate buffer (pH6) in microwave for antigen recovery, then treated with 
3% hydrogen peroxide to quench endogenous peroxidase activity. After washing, sections 
were placed on normal blocking solution, treated with rabbit polyclonal anti-TRPV4 
(Proteintech, UK) and AQP5 (Thermo Fischer Scientific, Hungary) primary antibodies in a 
dilution of 1:200 for 1 h at room temperature. Incubation was performed with the Histo-
Labeling system anti-rabbit secondary antibody conjugated with peroxidase (Histols Reagent, 
Hungary) and the reaction was visualized using 3,3-diaminobenzidine tetrachloride (Histols 
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DAB, Histols Reagent, Hungary). Histological counterstaining was performed with 
haematoxylin. For double immunofluorescence analysis, the Tyramide Signal Amplification 
Kit (Molecular Probes/Thermo Fischer Scientific, Hungary) was used with fluorescent-
labeled tyramide (Alexa Fluor 594-labeled, cat. no. T20925, Invitrogen, 1:100) to detect color 
red and directly labeled secondary antibody (Alexa Fluor 488 goat anti-rabbit, Invitrogen, 
1:200) to detect color green. Micrographs were generated using an Olympus Fluoview-1000 
system on an Olympus IX81 microscope stage equipped with an Olympus DP70 digital 
camera and through an Olympus UPlan FL N, Phase2 objective. The scale bar represents 
50 µm. The counting of TRPV4 and AQP positive myometrial cells was performed in 3 
different standardized areas from each slide, using ImageJ software. 
3.7 In Vitro Contractility Studies 
Uterus tissues were removed from the 18 or 22-day pregnant rats (n=6 in each experiment). 
5 mm long muscle rings were sliced from both horns of the uterus (2-2 rings were chosen 
from the centre of each horn) they were cleaned up of fat, the foeto-placental units were 
removed and mounted vertically in an organ bath containing 10 ml de Jongh solution 
(composition: 137 mM NaCl, 3 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 12 mM NaHCO3, 
4 mM NaH2PO4, 6 mM glucose, pH = 7.4). The temperature of the organ bath was maintained 
at 37 °C, and carbogen (95% O2 + 5% CO2) was perfused continuously through the bath. 
After mounting, the rings were allowed to equilibrate for approximately 60 min before 
experiments were started, with a buffer change every 15 min. The initial tension of the 
preparation was set to about 1.5 g and the tension dropped to about 0.5 g by the end of the 
equilibration period. The tension of the myometrial rings was measured with a gauge 
transducer (SG-02; Experimetria Ltd., Budapest, Hungary) and recorded with a SPEL 
Advanced ISOSYS Data Acquisition System (Experimetria Ltd., Budapest, Hungary). In the 
following step, spontaneous contractions were recorded for 4 minutes and cumulative 
oxytocin concentration–response curves (10-12−10-8 M) were constructed in each experiment. 
Following the addition of each concentration of oxytocin, recording was performed for 4 
minutes.  
For the investigation of the effects of TRPV4 agonist and antagonist compounds, 25 mM KCl 
solution was used to induce rhythmic contractions in the in vitro contractility studies. Without 
washing out the contractile agent, the effects of a TRPV4 antagonist (RN1734, Sigma-
Aldrich, Hungary) and a TRPV4 agonist (RN1747, Sigma-Aldrich, Hungary) were tested on 
the uterine contractions in the concentration range of 3x10-8-10-5 M in a cumulative mode. 
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Control uteri were treated with the solvent of the compounds. Recording was performed at 
each concentration of the examined agents for 5 minutes. The tension of the myometrial rings 
was measured with a strain gauge transducer (SG-02; MDE Ltd., Budapest, Hungary) and 
contractions were recorded and later analyzed with the SPEL Advanced ISOSYS Data 
Acquisition System (MDE Ltd., Budapest, Hungary). The effects of RN1734 and RN1747 
were expressed as the percentage of the area under curve (AUC) of KCl induced contractions. 
The dose-response curves were fitted and the statistical analysis of EC50 and Emax values was 
performed.  
3.8 Statistical Analysis 
All experiments were carried out on six animals and the molecular biology studies were 
repeated three times. Statistical analyses were performed using the Prism 5.0 software (Graph 
Pad Software, Inc., San Diego, CA, USA). ANOVA Dunnett’s test or two-tailed unpaired t 
test were used.  
The results of the isolated organ studies were analyzed with Dunnett’s multiple comparison 
tests. 
D'Agostino-Pearson omnibus test was performed to determine the normal distribution of the 
data. One-way ANOVA followed by Bonferroni's post hoc test was used for statistical 
analysis of the immunochemistry. The value of p< 0.05 was considered statistically 
significant. 
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4 Results 
4.1 The effects of estrogen analog compounds on AQP5 expression in pregnant rat 
uterus 
We found that 17β-estradiol pretreatment did not result any significant changes in the AQP5 
mRNA levels, it was inefficient both on day 18 and day 22 of gestation compared to the non-
treated control uterus (Fig. 5A). The protein expression of AQP5 showed a significantly 
increase both on day 18 and day 22 of pregnancy, compared to the control (Fig. 5B).  
 
In case of tamoxifen citrate pretreatment we did not observe any changes on the AQP5 
mRNA expression (Fig. 6A). However, the level of AQP5 protein elevated on day 18, but did 
not change on the last day of gestation, compared to the control (Fig. 6B). 
 
Either the AQP5 mRNA (Fig 7A) or the protein (Fig 7B) levels did not alter significantly as a 
result of clomiphene citrate pretreatment on the investigated days of pregnancy. 
 
Figure 5. Results of RT-PCR and Western immunoblotting analysis after 17β-estradiol treatment. The 
changes of mRNA and protein expression of AQP5 after 17β-estradiol (E) pretreatment in pregnant rat uterus on 
days 18 and 22. ns > 0.05, *** p < 0.001 as compared to the data of non-treated control. Each bar denotes the 
mean ± S. D. 
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Figure 6. Results of RT-PCR and Western immunoblotting analysis after tamoxifen citrate treatment. The 
changes of mRNA and protein expression of AQP5 after tamoxifen citrate (T) pretreatment in pregnant rat uterus 
on days 18 and 22. ns > 0.05, *p < 0.05 as compared to the data of non-treated control. Each bar denotes the 
mean ± S. D. 
 
Figure 7. Results of RT-PCR and Western immunoblotting analysis after clomiphene citrate treatment. 
The changes of mRNA and protein expression of AQP5 after clomiphene citrate (C) pretreatment in pregnant rat 
uterus on days 18 and 22. ns > 0.05 as compared to the data of non-treated control. Each bar denotes the mean ± 
S. D. 
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4.2 The effects of gestagen analog compounds on AQP5 expression in pregnant rat 
uterus 
All of the gestagen-related compounds: progesterone, levonorgestrel and 
medroxyprogesterone acetate pretreatment induced a significant raise both in AQP5 mRNA 
and protein levels on day 18 and day 22 of gestation (Fig. 8-10). 
 
Figure 8. Results of RT-PCR and Western immunoblotting analysis after progesterone treatment. The 
changes of mRNA and protein expression of AQP5 after progesterone (P) pretreatment in pregnant rat uterus on 
days 18 and 22. *** p < 0.001 as compared to the data of non-treated control. Each bar denotes the mean ± S. D. 
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Figure 9. Results of RT-PCR and Western immunoblotting analysis after levonorgestrel treatment. The 
changes of mRNA and protein expression of AQP5 after levonorgestrel (L) pretreatment in pregnant rat uterus 
on days 18 and 22. *** p < 0.001 as compared to the data of non-treated control. Each bar denotes the mean ± 
S. D. 
 
Figure 10. Results of RT-PCR and Western immunoblotting analysis after medroxyprogesterone acetate 
treatment. The changes of mRNA and protein expression of AQP5 after medroxyprogesterone acetate (MPA) 
pretreatment in pregnant rat uterus on days 18 and 22. *** p < 0.001 as compared to the data of non-treated 
control. Each bar denotes the mean ± S. D. 
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4.3 The effect of hormonally-induced preterm delivery on AQP5 expression in 
pregnant rat uterus 
We found a significant reduction of AQP5 mRNA and protein levels on day 20 of pregnancy, 
compared to the non-treated rats on pregnancy day 20. Interestingly this drop was similar to 
the physiological last day of gestation (Fig. 11) 
 
Figure 11. Results of RT-PCR and Western immunoblotting analysis after the hormonally-induced 
preterm delivery. The changes of mRNA and protein expression of AQP5 after hormonally-induced preterm 
birth (PB) in pregnant rat uterus. *** p < 0.001 as compared to the data of non-treated pregnancy day 20. Each 
bar denotes the mean ± S. D. 
 
4.4 The effects of different antibiotic drugs on AQP5 expression in pregnant rat uterus 
The AQP5 mRNA (Fig. 12A) and protein (Fig. 12B) levels showed a significant drop on day 
22 of pregnancy after the 7 days amoxicillin pretreatment, compared to the non-treated rat 
uterus on the last day of gestation. 
 
A single dose of fosfomycin significantly increased the AQP5 mRNA levels on the last day of 
pregnancy, compared to non-treated animals (Fig. 13A). In opposition to the mRNA level, the 
protein level of AQP5 showed reduction on day 22 of gestation (Fig. 13B). 
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In case of 7 days doxycycline pretreatment we did not observe any changes either in the 
AQP5 mRNA or the protein levels on the last day of pregnancy (Fig. 14). 
 
Figure 12. Results of RT-PCR and Western immunoblotting analysis after amoxicillin treatment. Changes 
in mRNA (A) and protein (B) expression of AQP5 after 7 days of amoxicillin (A) pretreatment in rat uterus on 
the last day of pregnancy. * p < 0.05 as compared to the non-treated uterus. Each bar denotes the mean ± S.D. 
 
Figure 13. Results of RT-PCR and Western immunoblotting analysis after fosfomycin treatment. Changes 
in mRNA (A) and protein (B) expression of AQP5 after fosfomycin (F) pretreatment in rat uterus on the last day 
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of pregnancy. ** p < 0.01, *** p < 0.001 as compared to the non-treated uterus. Each bar denotes the 
mean ± S.D. 
 
 
Figure 14. Results of RT-PCR and Western immunoblotting analysis after doxycycline treatment. Changes 
in mRNA (A) and protein (B) expression of AQP5 after doxycycline (D) pretreatment in rat uterus on the last 
day of pregnancy. ns p > 0.05 as compared to non-treated uterus. ns: non-significant. Each bar denotes the 
mean ± S.D. 
 
4.5 The effect of antibiotic pretreatment on the oxytocin evoked myometrial 
contractions in vitro 
As seen on Figure 15, oxytocin (10-12-10-8 M) enhanced the uterus contractions on day 22 of 
pregnancy. Amoxicillin or fosfomycin pretreatments significantly increased the uterine 
contracting effects of oxytocin. In contrast, doxycycline pretreatment did not influence the 
oxytocin-induced contractions (Fig. 15). 
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Figure 15. Effects of fosfomycin, amoxicillin and doxycycline pretreatment on the oxytocin-induced 
contractions in the 22-day pregnant rat uteri. The change in contraction was calculated by area under the 
curve alteration and expressed in % ± SD as compared to the area under the curve of control contractions. ns: 
non-significant; ns p > 0.05; * p < 0.05; ** p < 0.01. 
 
As for the spontaneous uterus contractions, it was decreased significantly by fosfomycin and 
amoxicillin pretreatment on the 22-day pregnant uterus. In opposition to doxycycline treated 
uterus, there was no change in the spontaneous contractility (Fig.16). 
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Figure 16. Spontaneous uterine contractility in the 22-day pregnant rats after fosfomycin, amoxicillin and 
doxycycline pretreatments. The changes of the area under the curve of spontaneous uterus contractions after 
the pretreatment with antibiotics compared to the non-treated uterus. Each value denotes the mean ± S.E.M.. ns: 
non-significant; ns p > 0.05; * p < 0.05; ** p < 0.01. 22: control 22-day pregnant rat uterus; F: fosfomycin; A: 
amoxicillin; D: doxycycline treated 22-day pregnant rat uterus 
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4.6 The TRPV4 and AQP5 co-expression in rat uterus 
We determined the TRPV4 mRNA and protein expression in the non-pregnant and pregnant 
rat uterus (Fig. 17). There is a correlation between the changes of the mRNA and protein 
levels on the investigated days. On day 18 of gestation, the mRNA and protein expression was 
the lowest, and it elevated continuously until the day of labor (Fig. 17A and B). From day 18 
to 22 of pregnancy, the AQP5 (Fig. 2) and TRPV4 mRNA expression (Fig. 17A) showed a 
strong correlation (r2=0.9577) (Fig. 17C). Between AQP5 and TRPV4 protein expression, we 
determined a moderate correlation (r2=0.6452) (Fig. 17D). 
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Figure 17. The changes in mRNA (A) and protein expression (B) of TRPV4 in the non-pregnant uterus 
(estrus phase) and on different gestational days in pregnant rat uterus. Correlation between TRPV4 and 
AQP5 mRNA (C) and protein (D) expression from pregnancy day 18 to day 22 in uterus. NP: non-pregnant, ns 
>0.05, * p<0.05, ** p<0.01, *** p<0.001; compared to the previous day.  
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On day 18 and 22 of gestation, the number of the AQP5 and TRPV4 channels show inverse 
expression but it was not significant change (Fig. 18D and E) in the myometrium, according 
to the immunohistochemical studies.  
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Figure 18. Representative pictures showing expressions of the AQP5 (A) and TRPV4 (B) ; these co-
expressions (C) and the number of AQP5 (D)/ TRPV4 (E) immunopositive cells in the myometrium on 
days 18 and 22 of pregnancy. ns >0.05, compared to day 18 of pregnancy. 
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On the last day of gestation, the numbers of AQP5 immunpositive cells were significantly 
decreased (Fig. 19D). On the other hand, the numbers of TRPV4 immunpositive cells were 
significantly elevated on day 22 (Fig. 19E).  
It was proven, that the AQP5 and TRPV4 channels are co-expressed in the endometrium and 
myometrium, on both investigated days of late gestation (Fig. 18C and 19C). 
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Figure 19. Representative pictures showing expressions of the AQP5 (A) and TRPV4 (B); these co-
expressions (C) and the number of AQP5 (D)/ TRPV4 (E) immunopositive cells in the endometrium on 
days 18 and 22 of pregnancy. * p<0.05, *** p<0.001 compared to day 18 of pregnancy. 
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It was also investigated, how the TRPV4 agonist and antagonist influence the uterus 
contraction in an isolated organ bath system (Fig. 20). The agonist (RN1747) displayed a 
minor relaxing effect on day 18 (9.93 %) in 10-5 M concentration. The antagonist (RN1734) 
showed a pronounced relaxing effect (30.33 %) on the same day and in the same 
concentration (Fig. 20A).  
On the last day of pregnancy, the agonist did not have any effect on relaxation (-16.87 %), but 
it induced uterus contraction. The antagonist had a remarkable relaxing effect (44.52 %) on 
day 22 of gestation (Fig. 20B). 
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Figure 20. Effect of selective TRPV4 agonist (RN1747) and antagonist (RN1734) on KCl-evoked control 
contraction of rat uteri on days 18 (A) and 22 (B) of gestation. The statistical analyses were carried out with 
the two-tailed unpaired t-test. Each value denotes the mean ± S.E.M, *p<0.05; ***p<0.001. 
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5 Discussion 
Our earlier studies revealed that AQP5 water channel is the one subtype of the AQP family 
which undergoes major changes in the course of gestation in pregnant rat uterus. There are 
numerous comprehensive studies which investigated AQP5 water channel in different species 
but to date, we cannot found any experiment that have focused on the expression of this 
channel in late pregnant rat uterus after the pretreatment of female sexual hormones or 
antibiotics. There is no data about the effect of antibiotics on the uterine contractility and the 
connection between AQP5 and TRPV4 channel in the pregnant rat uterus. 
5.1 AQP5 channel, female sexual hormones and preterm birth 
At the time of gestation several hormonal changes occur. In case of human, the two dominant 
female sexual hormones, estrogen and progesterone show a continually growing level during 
pregnancy. The serum progesterone level decreased slightly at the end of gestation, although 
the amount of estrogen in the blood stays elevated. (Boroditsky et al., 1978; Tulchinsky et al., 
1972) In pregnant rats, the progesterone level rises constantly at the time of gestation until 
day 19 of pregnancy, after that it drops dramatically. (Morishige et al., 1973) The serum 
estradiol level is consistent in rats, but it doubles from day 18 until day 21 of pregnancy. The 
amount of estradiol drops slightly on the last day of gestation. (Shaikh, 1971) 
There are evidences that the AQP water channels can be influenced by sexual hormones. For 
example, the expression of AQP1 channel is moderately regulated by estrogen in the non-
pregnant mouse uterus. The AQP2 level shows elevated expression as a result of estrogen. 
(Jablonski et al., 2003) Richard et al. revealed that the expression of AQP1, 4, and 5 elevated 
extremely at the time of implantation in the mouse myometrium. As a result of estrogen 
stimulation, the expression of AQP5 showed elevation on progesterone-primed uterus. 
(Richard et al., 2003) It is clear that AQP5 has an important role in the fluid regulation of 
uterus during the implantation period. The hormonal changes which regulate implantation are 
responsible for the positioning of AQP5 water channel in the uterus. (Lindsay and Murphy, 
2006) 
According to recent studies there is no information about the effects of female sexual 
hormones on the AQP5 expression in late pregnant rat uterus. In our study we found that 
progesterone pretreatment significantly increased the AQP5 expression. In case of 
progesterone, the AQP5 mRNA level was higher than the AQP5 protein level. In contrast, the 
protein expression increased similarly after levonorgestrel and medroxyprogesterone acetate 
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treatment, as compared to progesterone treatment. According to the basic perception of 
molecular biology, the information streams from DNA by the help of mRNA to proteins. 
There are variable factors which could impact this process that is why we cannot always find 
a solid correlation between mRNA and protein expression. (Maier et al., 2009)  
17β-estradiol pretreatment caused a significant increase in the amount of AQP5 protein, but 
did not result any changes in the AQP5 mRNA expression, both on day 18 and day 22 of 
gestation. In the light of our result, we presume that estrogen may protect the stability the 
AQP5 protein and this procedure could lead to the elevation in protein expression without 
modification of mRNA expression.  
Tamoxifen is a nonsteroidal triphenylethylene derivative with a selective estrogen receptor 
modulator effect. (Dutertre and Smith, 2000) The tamoxifen citrate pretreatment significantly 
increased the level of AQP5 protein on day 18 of gestation.  
Clomiphene citrate also has selective estrogen receptor modulator effect and it has 
nonsteroidal conformation too. (Hughes et al., 2000) Clomiphene citrate did not result any 
difference either in the AQP5 mRNA expression or in the AQP5 protein level. We presume 
that the four-day long pretreatment is not enough for influencing the hypothalamic-pituitary 
axis and evoke the hormonal changes. 
Preterm delivery could have different pathophysiological backgrounds, such as endocrine 
disorders, allergic phenomena, abnormal allograft reaction, cervical disease, uterine over-
distension, ischemia and infection.(Romero et al., 2006) This is the reason why we have 
various types of animal models for preterm birth. We wanted to prove that progesterone has 
notable effect on AQP5 expression, so we used hormonally-induced preterm birth model. 
Preterm delivery was induced by antigestagen mifepristone and intravaginal prostaglandin E2. 
The preterm birth was initiated by mifepristone which blocks the progesterone receptors. 
(Telleria and Deis, 1996) Prostaglandin E2 enables the induction of labor and the cervical 
ripening. (Thomas et al., 2014) The preterm birth started on day 20 of gestation in this model. 
The AQP5 mRNA and protein expression decreased significantly on day 20 of pregnancy 
when the preterm delivery begins. This change in the AQP5 expression was similar to the last 
day of gestation which occurs on day 22. This phenomenon could be explained by the 
process, during which the level of progesterone dropped significantly at the time of the 
preterm delivery, which was followed by the decrease of AQP5 expression. 
In the light of our results we can conclude that both estrogen and gestagen-related compounds 
can influence the expression of AQP5 water channel. Progesterone and the other gestagen 
hormones have more pronounced effect on the expression in the late pregnant rat uterus. The 
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hormonally-induced preterm birth model study suggests that the lack of progesterone leads to 
reduced AQP5 expression and may contribute to the initiation of preterm labor.  
5.2 AQP5 channel and antibiotic treatment 
Among the several risk factors which can lead to preterm birth, the most common are 
intrauterine inflammation and infection. (Epstein et al., 2000; Gonçalves et al., 2002) As the 
results show, the antimicrobial therapy seems to be the appropriate solution for prevent the 
preterm delivery and the complications of it. There is evidence about the usage of antibiotics 
in pregnancy with premature rupture of the membranes: it can prolong the period between the 
rupture of membranes and the onset of labor. (Ananth et al., 1996) The antibiotic treatment 
also can reduce the incidence of problems which are caused by preterm birth, for example: 
intraventricular hemorrhage, chorioamnionitis and neonatal infection. (Kenyon et al., 2013) 
Two randomized controlled studies examined the penicillin family of antibiotic drugs in case 
of preterm birth. These investigations did not found any positive effect as a result of antibiotic 
prophylaxis irrespective of the use of tocolysis or steroid treatment. (Kenyon et al., 2004, 
2001) 
We have information about the teratogenic effect and other risk factors about antibiotic drugs 
during gestation; however, no data is available regarding their response on the pregnant 
uterine contractility. Effect of antibiotics on uterine contractions can be an important question 
especially in a case, when a mother obtains antibiotic treatment. 
We investigated three different antibiotic drugs regarding their influence on the uterine 
contractions and additionally on the AQP5 expression. Our earlier results supported that the 
uterine contractility is inversely proportional to AQP5 expression. (Csányi et al., 2016; Ducza 
et al., 2014) Amoxicillin pretreatment significantly reduced the AQP5 level in the pregnant rat 
uterus on the last day of gestation. The uterine tissues showed enhanced contractility 
responses to oxytocin as a result of amoxicillin pretreatment, in the in vitro isolated organ 
experiment. (Csányi et al., 2018) This phenomenon might explain the ineffectiveness 
amoxicillin and other beta-lactam antibiotics in the prevention of preterm delivery. (Lee et al., 
2016) 
AQP5 mRNA level was significantly elevated while the protein level declined as a result of 
fosfomycin pretreatment. The AQP5 protein expression was reduced by fosfomycin 
pretreatment and this treatment increased the sensitivity of the uterus to oxytocin stimulation 
in the concentration of 10-8M.  
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Doxycycline pretreatment did not have any effect on the AQP5 expression or on the uterine 
contracting effect of oxytocin. 
Some studies investigated the effect of antibiotic treatment on the contractility of smooth 
muscles and they found that it can modulate directly the contractility. (Granovsky-Grisaru et 
al., 1998; Paradelis et al., 1982; Tagaya et al., 1995) Piccino et al. reported that three 
antibiotics (amoxicillin, enrofloxacin and rifaximin) can modulate the contractility of the non-
pregnant bovine uterine tissue. They revealed that amoxicillin has concentration-dependent 
relaxing effect on the basal contractility in the lutheal and follicular phases of the cycle. 
(Piccinno et al., 2016) 
Based on these results, we have found more evidence for the cross-talk between AQP5 and 
oxytocin in the control of uterine contraction. Even though the correct mechanism of this 
phenomenon is not clear, we presume that the changes in the cell volume by AQP5 were 
induced by antibiotics that influence the intracellular calcium concentration. It was earlier 
proved that high intracellular calcium concentration resulted elevated AQP5 expression in 
kidney cell lines, in which strongly expressed human AQP5 and also in eccrine sweat glands. 
(Concepcion et al., 2016; Inoue, 2016) The canonical pathway of the uterus stimulation of 
oxytocin is the calcium-dependent activation of calmodulin and myosin light chain kinase. It 
is a known fact that the oxytocin receptor density elevates at the onset of labor, it is enable the 
increased sensitivity of the uterine tissue to oxytocin which is essential for the normal process 
of delivery at term. 
We can conclude that amoxicillin and fosfomycin therapies may sensitize the uterus to 
oxytocin via the reduction of AQP5 expression. This synergetic effect must be considered in 
pharmacotherapy during pregnancy.  
5.3 Cooperation between the AQP5 channel and TRPV4 receptor  
The exact mechanisms of preterm delivery are largely unknown. The management of preterm 
birth involves the identification of the factors which induced the untimely uterine contraction. 
(Marzano et al., 2008) In our study we looked for new mechanisms through which uterine 
contraction is adjustable. 
It is well known, that AQPs are present during the gestation and they regulate somehow the 
uterus contractions and the cervical ripening during labor. (Ducza et al., 2017) The AQP5 
expression represented an increasing trend to the day 18 of pregnancy and this expression 
dramatically decreased on the last day of gestation in rat. It was also elucidated that this water 
channel is selectively down-regulated by oxytocin, which is responsible for uterus 
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contractions. (Ducza et al., 2014) The AQP5 expression was up-regulated by the uterus 
relaxing progesterone and progesterone-related compounds. (Csányi et al., 2016) According 
to these findings we confirmed an inverse correlation between AQP5 expression and 
myometrial contraction. We hypothesize that a low AQP5 level may induce or increase the 
contractility of late pregnant uterine tissue. The key question is the clarification of the 
mechanism of this phenomenon, especially at the time of delivery. We hypothesize an 
osmotic pathway to control the smooth muscle cells in the uterus. The main investigated days 
were the day 18 and 22 of pregnancy, because on these days were the most pronounced 
changes in the AQP5 and TRPV4 expression in rat uterus.  
The TRPV channels are present in the female and male reproductive tissues and they are 
responsible for different physiological function. For example, in rat prostatic tissue Guibert et 
al. observed TRPV4 expression. (Guibert et al., 2011) These channels enable the oocyte 
maturation and activation and also fertilization. (Björkgren and Lishko, 2017) Another study 
revealed TRPV1 expression in the human placenta and their abnormal function in 
preeclampsia. (Martínez et al., 2016) The TRPV6 is expressed in the bovine uterine 
endometrium and placenta during the gestation. (Sprekeler et al., 2012) 
The TRPV4 channel is a Ca2+ channel and it is activated by osmotic stimuli and it can be 
found in different smooth muscles. (Rosasco and Gordon, 2017) Based on current evidence, 
the calcium homeostasis is regulated in the uterine smooth muscle near term to facilitate the 
uterine contractility. The entry of extracellular Ca2+ enables the maintenance of spontaneous 
rhythmic contractions in the human uterus. (Parkington et al., 1999) 
It is well known that the AQP5 water channel is an interacting partner of the TRPV4 channel 
in the smooth muscles of the airway system and in the gastrointestinal tract. (Aure et al., 
2010; Sidhaye et al., 2006) There is a functional connection between AQP5 and TRPV4 in 
salivary glands. (Aure et al., 2010) According to other studies, the hypotonic reduction of 
AQP5 expression needs the TRPV4 action; moreover it is necessary for the mechanism of 
regulatory volume decrease in salivary gland cells. (Hosoi, 2016; Liu et al., 2006) 
In our study we determined the changes of TRPV4 expression in rat uterus during gestation. 
This alteration of TRPV4 expression in the uterus could be the effect of hormonal changes. 
TRPV4 expression was decreased by progesterone in human tracheal and mammary gland 
ductal epithelial cell lines. Decreased TRPV4 expression and promoter activity were also 
observed in the presence of progesterone in human aortic vascular smooth muscle cells (Jung 
et al., 2009) This statement supports our results, considering that the level of progesterone 
drops at the end of pregnancy (Boroditsky et al., 1978), which increases TRPV4 expression. It 
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is known from our previous results that AQP5 expression is up-regulated by progesterone. 
(Csányi et al., 2016) We suppose a potential hormone regulated cooperation between the 
AQP5 and TRPV4 expression. 
Based on our results we found an inverse correlation between the AQP5 and TRPV4 mRNA 
and protein expression. The putative cooperation between AQP5 and TRPV4 was revealed by 
our immunohistochemical findings. We proved the changes in the AQP5 and TRPV4 
expression and the co-expression of these proteins in the late pregnant rat uterus. 
In the volume homeostasis of brain there are a similar co-expression and functional 
relationship of TRPV4 and AQP4 channels. (Benfenati et al., 2011)  
Up to this day, different attempts were to modulate the entry of extracellular Ca2+ into the 
smooth muscle cells, and thereby regulate uterine contractility, but they are not efficient 
enough to prevent or delay the preterm birth. (Muglia and Katz, 2010) Current evidence 
suggests that uterine smooth muscle cell Ca2+ homeostasis is modulated near term to promote 
uterine contractility. TRPV4 might have a role in uterine contractility and Ca2+ signaling 
(Ying et al., 2015) We determined the effect of the TRPV4 channel in the regulation of late 
pregnant rat uterus contraction with TRPV4 agonist and antagonist. The TRPV4 agonist had a 
poor relaxing effect on the uterus contraction on day 18 in the highest concentration. In 
contrast, a contraction-inducing effect was measured on the last day of pregnancy. 
The TRPV4 antagonist (RN1734) completely inhibits both ligand-induced and hypotonicity-
induced activation of TRPV4, without modulating the function of other TRP channels. (White 
et al., 2016) We determined the relaxing effect of RN1734 on both investigated days; with the 
major effect on the last day of pregnancy. We presume it can be explained by the increased 
expression of TRPV4 and the decreased expression of AQP5. Singh et al. proved that the 
other type of TRPV4 antagonist (HC067047) inhibited the PGF2α induced contraction in non-
pregnant and pregnant mouse uterus. (Singh et al., 2015) There is no opportunity to examine 
the physiological role of AQP5 in the uterus contractions because of the lack of non-toxic 
tissue- and subtype-selective agonists or antagonists. 
Based on our findings we presume the decreased AQP5 expression triggers an osmotic stress, 
which activates TRPV4 and increases uterus contraction on the day of labor. This 
phenomenon can confirm the future role of TRPV4 antagonist in the tocolytic therapy. 
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6 Conclusion 
In the light of our results, we can conclude that (1) AQP5 expression is influenced by both 
female hormones with progesterone predominance in the late pregnant rat uterus.  
We found (2) a marked decrease of AQP5 levels in hormonally induced preterm model and 
this change in AQP5 expression was similar to the day of normal birth. The explanation for 
this phenomenon could be that in the preterm delivery, the progesterone level decreases 
significantly, followed by the reduction of AQP5 expression. These changes suggest that the 
lack of progesterone effect leads to reduced AQP5 expression and may contribute to the 
initiation of preterm labor. These results may confirm an inverse correlation between the 
AQP5 expression and uterus contraction. 
 
Antibiotics are used in pregnancy-associated urinary tract infections and to reduce the risk of 
infection-related preterm birth, especially in case of the premature rupture of the membranes. 
Some studies have reported the direct contractility modulating effect of antibiotics on smooth 
muscles. Based on our finding, (3) the therapy with amoxicillin and fosfomycin requires 
increased attention because they may sensitize the uterus to oxytocin via the reduction of 
AQP5 expression. This synergetic effect must be considered in pharmacotherapy during 
pregnancy. 
 
(4) Co-expression was demonstrated between the AQP5 and TRPV4 channels in the late 
pregnant rat uterus. The uterus relaxant effect of TRPV4 antagonist was proved (5) on the day 
of birth as a new target for the tocolysis. Based on our findings we presume the decreased 
AQP5 expression triggers an osmotic stress, which activates TRPV4 and increases uterus 
contraction on the day of labor. 
 
With these studies, we hope to give basic knowledge about the role of AQP5 in delivery and 
to obtain new information about the mechanism of preterm birth. Although the results stem 
from rats, the data may provide a basis for further studies in humans. 
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